{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:43:46Z","timestamp":1791434626691,"version":"4.3.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T00:00:00Z","timestamp":1430352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10928-015-9417-1","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T13:51:35Z","timestamp":1430315495000},"page":"301-314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Reporting guidelines for population pharmacokinetic analyses"],"prefix":"10.1007","volume":"42","author":[{"given":"Kevin","family":"Dykstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer Wenzel","family":"Torn\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Kastrissios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidal","family":"Al-Huniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonkyung","family":"Byon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,30]]},"reference":[{"key":"9417_CR1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF01060053","volume":"1980","author":"LB Sheiner","year":"1980","unstructured":"Sheiner LB, Beal SL (1980) Evaluation of methods for estimating population pharmacokinetic parameters I. Michaelis-menten model: routine clinical pharmacokinetic data. J Pharmacokin Biopharm 1980:553\u2013571","journal-title":"J Pharmacokin Biopharm"},{"key":"9417_CR2","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1177\/0091270010377788","volume":"50","author":"K Romero","year":"2010","unstructured":"Romero K, Corrigan B, Torn\u00f8e CW, Gobburu JV, Danhof M, Gillespie WR, Gastonguay MR, Meibohm B, Derendorf H (2010) Pharmacometrics as a discipline is entering the \u201cindustrialization\u201d phase: standards, automation, knowledge sharing, and training are critical for future success. J Clin Pharmacol 50:9S\u201319S","journal-title":"J Clin Pharmacol"},{"key":"9417_CR3","unstructured":"US Food and Drug Administration (1999) Guidance for industry: population pharmacokinetics. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM072137.pdf . Accessed 30 Mar 2014"},{"issue":"2","key":"9417_CR4","doi-asserted-by":"crossref","first-page":"E456","DOI":"10.1208\/aapsj070245","volume":"7","author":"JR Wade","year":"2005","unstructured":"Wade JR, Edholm M, Salmonson T (2005) A guide for reporting the results of population pharmacokinetic analyses: a Swedish perspective. AAPS J 7(2):E456\u2013E460","journal-title":"AAPS J"},{"key":"9417_CR5","unstructured":"Committee for Medicinal Products for Human Use (2007) Guideline on reporting the results of population pharmacokinetic analyses. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003067.pdf . Accessed 30 Mar 2014"},{"key":"9417_CR6","first-page":"1","volume":"2(e51)","author":"W Byon","year":"2013","unstructured":"Byon W, Smith MK, Chan P, Tortorici MA, Riley S, Dai H, Dong J, Ruiz-Garcia A, Sweeney K, Cronenberger C (2013) Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance. CPT:PSP 2(e51):1\u20138","journal-title":"CPT:PSP"},{"issue":"4","key":"9417_CR7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1208\/s12248-012-9387-9","volume":"14","author":"PL Bonate","year":"2012","unstructured":"Bonate PL, Strougo A, Desai A, Roy M, Yassen A, van der Walt JS, Kaibara A, Tannenbaum S (2012) Guidelines for the quality control of population pharmacokinetic-pharmacodynamic analyses: an industry perspective. AAPS J 14(4):749\u2013758","journal-title":"AAPS J"},{"key":"9417_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40262-013-0114-1","volume":"53","author":"KM Jamsen","year":"2014","unstructured":"Jamsen KM, McLeay SC, Barras A, Green B (2014) Reporting a population pharmacokinetic-pharmacodynamic study: a journal\u2019s perspective. Clin Pharmacokinet 53:111\u2013122","journal-title":"Clin Pharmacokinet"},{"key":"9417_CR9","unstructured":"Karlsson MO, Holford N (2008) A tutorial on visual predictive checks. PAGE 17, Abstr 1434. http:\/\/www.page-meeting.org\/default.asp?abstract=1434 . Accessed 4 Apr 2015"},{"key":"9417_CR10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","volume":"28","author":"SL Beal","year":"2001","unstructured":"Beal SL (2001) Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn 28:481\u2013504","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9417_CR11","unstructured":"US Food and Drug Administration (2014) Pharmacometrics at FDA. http:\/\/www.fda.gov\/AboutFDA\/CentersOffices\/OfficeofMedicalProductsandTobacco\/CDER\/ucm167032.htm . Accessed 4 Apr 2015"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-015-9417-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-015-9417-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-015-9417-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T23:13:58Z","timestamp":1553642038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-015-9417-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,30]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["9417"],"URL":"https:\/\/doi.org\/10.1007\/s10928-015-9417-1","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,30]]}}}